Pricing news
Every pricing development we have covered, newest first.
5 dated pricing items. Most recent: Novo cuts self-pay pen pricing to $349 a month (2026-07-15).
All-in monthly cost at 2.4 mg
Stories in this category
Novo cuts self-pay pen pricing to $349 a month
Direct cash pricing for the branded pen falls well below list, narrowing the gap compounded prog…
Membership stacking spreads across semaglutide programmes
Several platforms now split the charge into medication plus a mandatory platform fee.…
First-month promotional rates published as ongoing prices
A recurring error across round-ups, and the likely origin of several wrong figures.…
The same molecule, two brands, a sevenfold price gap
The reformulated oral semaglutide sells near $149 a month while the older Rybelsus brand still l…
NovoCare Pharmacy opens a direct cash channel
The manufacturer begins selling to cash-paying patients directly, from a reported $149 for some …
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.